Reversible nocturnal enuresis in children receiving SSRI with or without risperidone: Presentation of five cases

Israel Journal of Psychiatry and Related Sciences

Volumn 41, Issue 3, 2004, Pages 218-221

  Kandil, Sema Tanriover ^a   Aksu, Hatice Bagdatli ^a   Ozyavuz, Rasin ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; HALOPERIDOL; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ANAMNESIS; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; CHILD; CLINICAL ARTICLE; COGNITIVE THERAPY; DATA ANALYSIS; DEPRESSION; DOSE RESPONSE; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NOCTURNAL ENURESIS; OBSESSIVE COMPULSIVE DISORDER; PATIENT COMPLIANCE; TIC; UROLOGY;

EID: 13644263322     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington D.C.: American Psychiatric Association, 1994.
2. Malone RP, Maislin G, Choudhury MS, Gifford C, Delaney MA. Risperidone treatment in children and adolescents with autism short- and long-term safety and effectiveness. J Am Acad Child Adolesc Psychiatry 2002;41:140-147.
3. Murdoch D, McTavish D. Sertraline: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 1992;44:604-624.
4. Poyurovsky M, Weizman A. Risperidone-induced nocturnal enuresis. Isr J Psychiatry Relat Sci 1997;34:247-248.
5. Bennett JA, Keck PE Jr, Wallhausser L J. Desmopressin for risperidone-induced enuresis. Ann Clin Psychiatry 1994;6:139-140.
6. Took KJ, Buck BL. Enuresis with combined risperidone and SSRI use. Letter. J Am Acad Child Adolesc Psychiatry 1996;35:840-841.
7. Toros F. Paroxetine induced enuresis. Letter. Eur Psychiatry 2003;18:43-44.
8. Feeney DJ, Klykylo WM. SSRI treatment of enuresis. J Am Acad Child Adolesc Psychiatry 1997;36:1326-1327.
9. Murray ME. Treatment of enuresis with paroxetine. J Dev Behav Pediatr 1997;18: 435-436.
10. Sprenger D. Sertraline for nocturnal enuresis. J Am Acad Child Adolesc Psychiatry, 1997;36:304-305.
11. Hirose S, Ashby CR, Jr. An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy. J Clin Psychiatry, 2002;63:733-736.
12. Peretti S, Judge R, Hindmarch I. Safety and tolerability considerations: Tricyclic antidepressants vs. selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000; 403:17-25.
13. Kalyoncu NI, Ozyavuz R, Karaoglu S. Sertraline inhibits the contractile responses to noradrenaline, KCl and electrical field stimulation of rat isolated vas deferens. J Auton Pharmacol 1999;19:365-369.
14. Yaris E, Kesim M, Kadioglu M, Kalyoncu NI, Ulku C, Ozyavuz R. The effects of paroxetine on rat isolated vas deferens. Pharmacol Res 2003;48:335-345.
15. Devane CL. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 1999;19:443-466.
16. Park KS, Kong ID, Park KC, Lee JW. Fluoxetine inhibits L-type Ca2+ and transient outward K+ currents in rat ventricular myocytes. Yonsei Med J 1999;40:144-151.
17. Garland EJ, Baerg EA. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. J Child Adolesc Psychopharmacol 2001;11:181-186.